Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3612973
Max Phase: Preclinical
Molecular Formula: C12H11F3N2S
Molecular Weight: 272.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3612973
Max Phase: Preclinical
Molecular Formula: C12H11F3N2S
Molecular Weight: 272.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=CC(c2ccc(C(F)(F)F)cc2)NC(=S)N1
Standard InChI: InChI=1S/C12H11F3N2S/c1-7-6-10(17-11(18)16-7)8-2-4-9(5-3-8)12(13,14)15/h2-6,10H,1H3,(H2,16,17,18)
Standard InChI Key: UZJDKLNGOVPUJF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 272.30 | Molecular Weight (Monoisotopic): 272.0595 | AlogP: 3.13 | #Rotatable Bonds: 1 |
Polar Surface Area: 24.06 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.24 | CX Basic pKa: | CX LogP: 2.84 | CX LogD: 2.84 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.77 | Np Likeness Score: -0.77 |
1. Seebacher W, Faist J, Presser A, Weis R, Saf R, Kaserer T, Temml V, Schuster D, Ortmann S, Otto N, Bauer R.. (2015) Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2., 101 [PMID:26197159] [10.1016/j.ejmech.2015.07.003] |
Source(1):